» Articles » PMID: 25502776

Functional Role of Calstabin2 in Age-related Cardiac Alterations

Overview
Journal Sci Rep
Specialty Science
Date 2014 Dec 16
PMID 25502776
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Calstabin2 is a component of the cardiac ryanodine receptor (RyR2) macromolecular complex, which modulates Ca(2+) release from the sarcoplasmic reticulum in cardiomyocytes. Previous reports implied that genetic deletion of Calstabin2 leads to phenotypes related to cardiac aging. However, the mechanistic role of Calstabin2 in the process of cardiac aging remains unclear. To assess whether Calstabin2 is involved in age-related heart dysfunction, we studied Calstabin2 knockout (KO) and control wild-type (WT) mice. We found a significant association between deletion of Calstabin2 and cardiac aging. Indeed, aged Calstabin2 KO mice exhibited a markedly impaired cardiac function compared with WT littermates. Calstabin2 deletion resulted also in increased levels of cell cycle inhibitors p16 and p19, augmented cardiac fibrosis, cell death, and shorter telomeres. Eventually, we demonstrated that Calstabin2 deletion resulted in AKT phosphorylation, augmented mTOR activity, and impaired autophagy in the heart. Taken together, our results identify Calstabin2 as a key modulator of cardiac aging and indicate that the activation of the AKT/mTOR pathway plays a mechanistic role in such a process.

Citing Articles

The Impact of Vitamin E Supplementation on Oxidative Stress, Cognitive Functions, and Aging-Related Gene Expression in Aged Mice.

Molavi Vasei F, Zamanian M, Golmohammadi M, Mahmoodi M, Khademalhosseini M, Tavakoli T Food Sci Nutr. 2024; 12(11):9834-9845.

PMID: 39619965 PMC: 11606824. DOI: 10.1002/fsn3.4548.


Dysfunctional mitochondria elicit bioenergetic decline in the aged heart.

Mone P, Agyapong E, Morciano G, Jankauskas S, De Luca A, Varzideh F J Cardiovasc Aging. 2024; 4(2).

PMID: 39015481 PMC: 11250775. DOI: 10.20517/jca.2023.50.


Comprehensive machine learning models for predicting therapeutic targets in type 2 diabetes utilizing molecular and biochemical features in rats.

Matboli M, Al-Amodi H, Khaled A, Khaled R, Roushdy M, Ali M Front Endocrinol (Lausanne). 2024; 15:1384984.

PMID: 38854687 PMC: 11157016. DOI: 10.3389/fendo.2024.1384984.


Integrated Analysis of lncRNA-miRNA-mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits.

Samidurai A, Olex A, Ockaili R, Kraskauskas D, Roh S, Kukreja R Cells. 2023; 12(24).

PMID: 38132140 PMC: 10742118. DOI: 10.3390/cells12242820.


NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation.

Ramos-Mondragon R, Lozhkin A, Vendrov A, Runge M, Isom L, Madamanchi N Antioxidants (Basel). 2023; 12(10).

PMID: 37891912 PMC: 10604902. DOI: 10.3390/antiox12101833.


References
1.
Sardu C, Marfella R, Santulli G . Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people. J Cardiovasc Transl Res. 2014; 7(3):362-8. DOI: 10.1007/s12265-014-9545-9. View

2.
Huang F, Shan J, Reiken S, Wehrens X, Marks A . Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice. Proc Natl Acad Sci U S A. 2006; 103(9):3456-61. PMC: 1413925. DOI: 10.1073/pnas.0511282103. View

3.
Vest J, Wehrens X, Reiken S, Lehnart S, Dobrev D, Chandra P . Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 2005; 111(16):2025-32. DOI: 10.1161/01.CIR.0000162461.67140.4C. View

4.
Armanios M . Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest. 2013; 123(3):996-1002. PMC: 3673231. DOI: 10.1172/JCI66370. View

5.
Santulli G, Totary-Jain H . Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics. 2013; 14(12):1517-26. PMC: 4186793. DOI: 10.2217/pgs.13.143. View